Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK706769 for Remission Maintenance in RA
NCT00979771Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Feb 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK706769 in rheumatoid arthritis (RA), sponsored by GSK. Planned start Feb 2010; status: withdrawn.
02
Drugs
GSK706769
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00979771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979771.